Rephonic
Artwork for BiotechTV

BiotechTV - News

BiotechTV
Orexin
FDA
Narcolepsy
Takeda
Alkermes
Biogen
Alnylam
Biotechnology
Cedar
Biotech Sector
Pfizer
Xenon
Stoke
China
Clinical Trials
RNA Interference
AI In Biotech
Duchenne Muscular Dystrophy
Axsome Therapeutics
Peanut Allergy

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

PublishesDailyEpisodes387Foundeda year ago
Number of ListenersCategories
Life SciencesScience

Listen to this Podcast

Artwork for BiotechTV

Latest Episodes

He describes learnings from Afrezza's commercialization, why the company acquired scPharmaceuticals, an update on their partnership with United Therapeutics in PAH, and a key IPF asset that is in the pipeline.

He argues that investors are too focused on each percentage of weight loss and not focused enough on the tolerability of new options. He discusses the timeline for the phase 3 that will likely start later this year, and how it might look different th... more

Maneet Singh says that pharma companies need to keep buying, and have the financial wherewithal to do it. He also gives thoughts on which areas within biotech could attract the most interest.

Key Facts

Accepts Guests
Accepts Sponsors
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Recent Guests

Michael Castagna
CEO of MannKind Corporation
MannKind Corporation
Episode: Barclays Miami: MannKind CEO Michael Castagna shares an update on the company, including a recent $360M acquisition, and two regulatory reviews at FDA that have decision dates over the coming months
Etzer Darout
Senior Biotech Analyst at Barclays
Barclays
Episode: Barclays Miami: Barclays' Senior Biotech Analyst Etzer Darout shares his take on biotech and discusses companies he covers that have been in the news
Adam Steensberg
CEO of Zealand Pharma
Zealand Pharma
Episode: Barclays Miami: Zealand Pharma CEO Adam Steensberg makes the case for last week's amylin data
Maneet Singh
Head of Healthcare M&A at Barclays
Barclays
Episode: Barclays Miami: Barclays' Head of Healthcare M&A shares his take on the current environment of dealmaking
Greg Mayes
CEO of Reunion Neuroscience
Reunion Neuroscience
Episode: Reunion Neuroscience recently received Breakthrough Therapy Designation from FDA for its psychedelic based treatment for postpartum depression (PPD)
Pravin Dugel
Chair, President, and CEO of Ocular Therapeutics
Ocular Therapeutics
Episode: Barclays Miami: Ocular Therapeutix's Chair Pravin Dugel discusses feedback he has been receiving on SOL-1 since announcing it last month
Bassil Dahiyat
President and CEO of Xencor
Xencor
Episode: Barclays Miami: Xencor CEO Bassil Dahiyat discusses the company's internal pipeline and how bi-specifics and other modalities are engineered to be increasingly sophisticated and more precise
Nancy Whiting
CEO of Recludix Pharma
Recludix Pharma
Episode: Barclays Miami: Recludix believes the time is right in science to drug SH2 domains. The company's lead programs target STAT6 and BTK
David Campbell
Founder and Chief Executive Officer, Janux Therapeutics
Janux Therapeutics
Episode: Barclays Miami: Janux's Founder & CEO David Campbell shares his thoughts on the company's PSMA x CD3 masked T-cell engager and discusses next steps. Plus, a CD19 for autoimmune

Host

Brad
Host of Biotech TV, leading discussions with various biotech leaders and experts.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Barclays Miami: Teva CEO Richard Francis talks about the company's emphasis on developing innovative medicines - including two recent financial deals to speed up development of IL-15 and TL1A
Q: So tell us a little bit more about pivot to growth and why it's important and how it's going.
The strategy was put in place in 2023 after years of revenue decline and consists of three phases: return to growth, accelerate growth, and maintain growth, with a focus on accelerating our innovative pipeline and stabilizing our genomics business.
Barclays Miami: Janux's Founder & CEO David Campbell shares his thoughts on the company's PSMA x CD3 masked T-cell engager and discusses next steps. Plus, a CD19 for autoimmune
Q: What are the next steps for the 007 program in prostate cancer?
Proceed with 10–20 patients in dose cohorts this year, engage with the FDA by year-end or early next year, and initiate pivotal studies in 2027.
Barclays Miami: Janux's Founder & CEO David Campbell shares his thoughts on the company's PSMA x CD3 masked T-cell engager and discusses next steps. Plus, a CD19 for autoimmune
Q: How is CRS being managed and what changed since earlier data releases?
A robust CRS mitigation approach was developed; earlier higher-grade CRS incidents were associated with a previous mitigation strategy, but current data show only low-grade events within the chosen dose range.
Barclays Miami: Janux's Founder & CEO David Campbell shares his thoughts on the company's PSMA x CD3 masked T-cell engager and discusses next steps. Plus, a CD19 for autoimmune
Q: What were the key updates from the December update and their significance?
The team clarified dosing schedules (Q2W), identified a target dose, and established a CRS mitigation strategy that maintains mostly Grade 1–2 CRS, enabling progression toward pivotal studies.
Barclays Miami: Janux's Founder & CEO David Campbell shares his thoughts on the company's PSMA x CD3 masked T-cell engager and discusses next steps. Plus, a CD19 for autoimmune
Q: What is the elevator pitch version of masking and why it's needed?
Masking aims to increase active drug delivery to tumors while reducing activity in healthy tissue, thereby enhancing tumor responses and limiting toxicities.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About BiotechTV

What is BiotechTV about and what kind of topics does it cover?

Content focuses on cutting-edge advancements in biotechnology and healthcare, featuring insights from leading industry figures and discussing the latest innovations in drug development, treatment therapies, and biotech trends. Episodes frequently highlight significant biotechnology conferences, showcasing the perspectives of CEOs and experts on their respective companies and the broader industry landscape. A distinctive aspect is the emphasis on the intersection of technology and biotechnology, along with the incorporation of artificial intelligence in drug discovery and therapy development, which may appeal to listeners interested in the future of health and medical research. The content is ideal for professionals in the life sciences and ... more

Where can I find podcast stats for BiotechTV?

Rephonic provides a wide range of podcast stats for BiotechTV. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to BiotechTV and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does BiotechTV get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for BiotechTV, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for BiotechTV?

Rephonic provides comprehensive predictive audience data for BiotechTV, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does BiotechTV have?

To see how many followers or subscribers BiotechTV has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to BiotechTV?

These podcasts share a similar audience with BiotechTV:

1. BioVenture VoiCes with Chris Garabedian
2. The Daily
3. Business Of Biotech
4. BioCentury This Week
5. The BioCentury Show

How many episodes of BiotechTV are there?

BiotechTV launched a year ago and published 387 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact BiotechTV?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for BiotechTV?

Rephonic pulls ratings and reviews for BiotechTV from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for BiotechTV?

Rephonic provides full transcripts for episodes of BiotechTV. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on BiotechTV?

Recent guests on BiotechTV include:

1. Michael Castagna
2. Etzer Darout
3. Adam Steensberg
4. Maneet Singh
5. Greg Mayes
6. Pravin Dugel
7. Bassil Dahiyat
8. Nancy Whiting

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days